National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 09/05/2008
Table 6. Characteristics of Low-Risk Patients with High Cure Rates Using Three-Drug Therapy

Site  Size  Group  Nodes 
Favorable Any I, II, III (not IV) N1
Favorable (non-orbit) Any III
Unfavorable T1 II N1
Unfavorable T1 Any N1
Unfavorable T2 I, II Any


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov